AIMS: This paper reports the results of a survey of national tobacco dependence treatment services in 36 countries. The objective was to describe the services and discuss the results in the context of Article 14 of the Framework Convention on Tobacco Control, which asks countries to promote adequate treatment for tobacco dependence. DESIGN, SETTING AND PARTICIPANTS: A questionnaire on tobacco dependence treatment services was e-mailed to a convenience sample of contacts in 2007. Completed questionnaires were received from contacts in 36 countries. MEASUREMENTS: The survey instrument was a 10-item questionnaire asking about treatment policy and practice, including medications. FINDINGS: According to our informants, fewer than half the countries in our survey had an official written policy on (44%), or a government official responsible for (49%), treatment. Only 19% had a specialized national treatment system and only 24% said help was easily available in general practice. Most countries (94%) allowed the sale of nicotine replacement therapy (NRT), bupropion (75%) and varenicline (69%) but only 40% permitted NRT on 'general sale'. Very few countries responding to the question fully reimbursed any of the medications. Fewer than half (45%) fully reimbursed brief advice and only 29% fully reimbursed intensive specialist support. Only 31% of countries said that their official treatment policy included the mandatory recording of patients' smoking status in medical notes. CONCLUSION: Taken together, our findings show that few countries have well-developed tobacco dependence treatment services and that, at a national level, treatment is not yet a priority in most countries.
AIMS: This paper reports the results of a survey of national tobacco dependence treatment services in 36 countries. The objective was to describe the services and discuss the results in the context of Article 14 of the Framework Convention on Tobacco Control, which asks countries to promote adequate treatment for tobacco dependence. DESIGN, SETTING AND PARTICIPANTS: A questionnaire on tobacco dependence treatment services was e-mailed to a convenience sample of contacts in 2007. Completed questionnaires were received from contacts in 36 countries. MEASUREMENTS: The survey instrument was a 10-item questionnaire asking about treatment policy and practice, including medications. FINDINGS: According to our informants, fewer than half the countries in our survey had an official written policy on (44%), or a government official responsible for (49%), treatment. Only 19% had a specialized national treatment system and only 24% said help was easily available in general practice. Most countries (94%) allowed the sale of nicotine replacement therapy (NRT), bupropion (75%) and varenicline (69%) but only 40% permitted NRT on 'general sale'. Very few countries responding to the question fully reimbursed any of the medications. Fewer than half (45%) fully reimbursed brief advice and only 29% fully reimbursed intensive specialist support. Only 31% of countries said that their official treatment policy included the mandatory recording of patients' smoking status in medical notes. CONCLUSION: Taken together, our findings show that few countries have well-developed tobacco dependence treatment services and that, at a national level, treatment is not yet a priority in most countries.
Authors: M Raw; P Anderson; A Batra; G Dubois; P Harrington; A Hirsch; J Le Houezec; A McNeill; D Milner; M Poetschke Langer; W Zatonski Journal: Tob Control Date: 2002-03 Impact factor: 7.552
Authors: Ron Borland; Lin Li; Pete Driezen; Nick Wilson; David Hammond; Mary E Thompson; Geoffrey T Fong; Ute Mons; Marc C Willemsen; Ann McNeill; James F Thrasher; K Michael Cummings Journal: Addiction Date: 2012-01 Impact factor: 6.526
Authors: Henri-Jean Aubin; Gérard Peiffer; Anne Stoebner-Delbarre; Eric Vicaut; Yasmine Jeanpetit; Anne Solesse; Geneviève Bonnelye; Daniel Thomas Journal: BMC Public Health Date: 2010-02-26 Impact factor: 3.295
Authors: Lenka Stepankova; Eva Kralikova; Kamila Zvolska; Alexandra Kmetova; Milan Blaha; Zbynek Bortlicek; Michal Sticha; Martin Anders; Darrell R Schroeder; Ivana T Croghan Journal: Prev Chronic Dis Date: 2013-09-19 Impact factor: 2.830
Authors: Gina R Kruse; Nancy A Rigotti; Martin Raw; Ann McNeill; Rachael Murray; Hembadoon Piné-Abata; Asaf Bitton; Andy McEwen Journal: J Smok Cessat Date: 2016-10-03
Authors: Alessandra Di Pucchio; Enrica Pizzi; Giordano Carosi; Monica Mazzola; Donatella Mattioli; Roberta Pacifici; Simona Pichini Journal: Int J Environ Res Public Health Date: 2009-02-26 Impact factor: 3.390